Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs-Reference-Cited by-同舟云学术

Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs

Published:2003-12 Issue:12 Volume:25 Page:3147-3161
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Fairman Kathleen A.,Motheral Brenda R.,Henderson Rochelle R.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference19 articles.

1. Job-based health benefits in 2002: Some important trends;Gabel;Health Aff (Millwood),2002

2. The effect of drug co-payments on utilization and cost of pharmaceuticals in a health maintenance organization;Harris;Med Care,1990

3. The impact of increasing patient prescription drug cost sharing on therapeutic classes of drugs received and on the health status of elderly HMO members;Johnson;Health Serv Res.,1997

4. Employer drug benefit plans and spending on prescription drugs;Joyce;JAMA,2002

5. Employer drug benefit plans and spending on prescription drugs;Joyce;JAMA,2002

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Employer-Led Strategies to Improve the Value of Health Spending;Journal of Occupational & Environmental Medicine;2021-10-05

2. Financial Burden of Prescribed Medicines Included in Outpatient Benefits Package Schemes: Comparative Analysis of Co-Payments for Reimbursable Medicines in European Countries;Applied Health Economics and Health Policy;2019-09-11

3. Novel Type 2 Diabetes Medication Access and Effect of Patient Cost Sharing;Journal of Managed Care & Specialty Pharmacy;2018-09

4. The Effect of Florida Medicaid’s State-Mandated Formulary Provision on Prescription Drug Use and Health Plan Costs in a Medicaid Managed Care Plan;Journal of Managed Care & Specialty Pharmacy;2018-02

5. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence;Journal of Clinical Pharmacy and Therapeutics;2016-01-18